These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32096684)

  • 1. The effect of Hepatitis D co-infection on the immunologic and molecular profile of Hepatitis B in asymptomatic Chronic Hepatitis B patients in southwest Nigeria.
    Akande KO; Fowotade A; Adekanmbi O
    J Immunoassay Immunochem; 2020 May; 41(3):272-280. PubMed ID: 32096684
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Hepatitis D Among Patients with Hepatitis B Viral Infection Attending a Tertiary Care Centre of Nepal.
    Regmi K; Shrestha JK; Sudhamshu KC; Jaishi B; Karki N; Khadka D; Khadka S
    JNMA J Nepal Med Assoc; 2017; 56(208):417-20. PubMed ID: 29453472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider.
    Bahcecioglu IH; Aygun C; Gozel N; Poyrazoglu OK; Bulut Y; Yalniz M
    J Viral Hepat; 2011 Jul; 18(7):518-24. PubMed ID: 20546500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis D virus antibodies and liver function profile among patients with chronic hepatitis B infection in Abuja, Nigeria.
    Abdulkareem LO; Ndububa DA; Uhunmwangho AO; Yunusa T
    J Infect Dev Ctries; 2021 Jan; 15(1):141-146. PubMed ID: 33571156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach.
    Khan AU; Waqar M; Akram M; Zaib M; Wasim M; Ahmad S; Niaz Z; Ali S; Ali H; Idrees M; Bajwa MA
    Virol J; 2011 Sep; 8():420. PubMed ID: 21888671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing seroprevalence of anti-hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019.
    Lee KC; Lin CL; Hsu CW; Chang ML; Chen YC; Lin WR; Lai MW; Lin KH; Chao M; Chien RN; Yeh CT
    J Med Virol; 2020 Jan; 92(1):124-127. PubMed ID: 31469172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medical impact of hepatitis D virus infection in Uzbekistan.
    Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Ismoilov U; Colombo M; Caviglia GP; Rizzetto M; Musabaev E
    Liver Int; 2019 Nov; 39(11):2077-2081. PubMed ID: 31505080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria.
    Opaleye OO; Japhet OM; Adewumi OM; Omoruyi EC; Akanbi OA; Oluremi AS; Wang B; Tong Hv; Velavan TP; Bock CT
    Virol J; 2016 Apr; 13():61. PubMed ID: 27044424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Hepatitis B virus and Hepatitis D virus Coinfection in Western Burkina Faso and molecular characterization of the detected virus strains.
    Sanou AM; Benkirane K; Tinto B; Cissé A; Sagna T; Ilboudo AK; Dording C; Tarnagda Z; Muller CP; Hübschen JM
    Int J Infect Dis; 2018 May; 70():15-19. PubMed ID: 29432880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence, co-infection and risk of transmission of Hepatitis B and D virus among hospital attendees in two South-western states in Nigeria.
    Sobajo OA; George UE; Osasona OG; Eromon P; Aborisade OY; Ajayi OD; Folarin OA; Komolafe IOO
    J Immunoassay Immunochem; 2023 Mar; 44(2):133-146. PubMed ID: 36369932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran.
    Attaran MS; Sharifi Z; Hosseini SM; Samei S; Ataee Z
    APMIS; 2014 Mar; 122(3):243-7. PubMed ID: 23879563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.
    Mohammad Alizadeh AH; Ranjbar M; Tehrani AS; Keramat F; Mamani M; Rezazadeh M; Aini P; Khalilian A; Majlesi A; Hajilooi M
    J Microbiol Immunol Infect; 2010 Dec; 43(6):519-23. PubMed ID: 21195980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection.
    Ricco G; Popa DC; Cavallone D; Iacob S; Salvati A; Tabacelia D; Oliveri F; Mascolo G; Bonino F; Yuan Q; Xia NS; Gheorghe L; Brunetto MR
    J Viral Hepat; 2018 Aug; 25(8):911-919. PubMed ID: 29577518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum β2-microglobulin in individuals coinfected with hepatitis B and hepatitis D virus in a rural settings in Southwest Nigeria.
    Okoror LE; Ajayi AO; Ijalana OB
    BMC Res Notes; 2017 Dec; 10(1):719. PubMed ID: 29221492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features.
    Makhlouf NA; Morsy KH; Mahmoud AA
    J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of disease activity in patients of chronic hepatitis B virus, with and without superinfection with hepatitis D virus; an experience at tertiary care centre.
    Das K; Ali H; Mahmood T; Munir SM; Ahmed T; Farooq MU
    J Ayub Med Coll Abbottabad; 2008; 20(2):39-42. PubMed ID: 19385455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.